USP5 can facilitate cancer progression, including NSCLC, through deubiquitination and stabilization of several downstream target proteins, including β-catenin, SLUG, FoxM1, Cyclin D1, and PD-L113,15–19. This evidence concerns the gene USP5 and non-small cell lung carcinoma.